Cobodoc, Inc.

Cobodoc has revolutionized surgical robotics with the world’s first collaborative and intelligent surgical cobotics system, engineered to precisely track and treat moving visceral targets during minimally invasive procedures. Successfully validated through rigorous animal trials, our proof of concept has demonstrated the system’s precision, safety, and significant benefits for patient outcomes. The Cobodoc system seamlessly integrates into standard cancer treatment protocols within operating rooms, offering a transformative approach to modern surgery. Our technology is protected by patents in both the US and EU, ensuring strong intellectual property coverage and a competitive market advantage. Designed for rapid deployment, this advanced yet cost-effective solution excels in emergency situations—delivering critical medical care to populations in need, providing urgent assistance to wounded soldiers and civilians, and ensuring uninterrupted care in high-stakes environments. By addressing staffing challenges in the healthcare sector, Cobodoc makes cutting-edge surgical robotics more accessible, empowering medical teams to provide superior care when it matters most. Following our successful proof of concept and robust IP protection, Cobodoc is now actively seeking investors to accelerate product development, regulatory approval, and market entry. We invite partners who share our vision to join us in transforming surgical care and making life-saving technology available to more patients worldwide.